SCHEMBL19979103

SCHEMBL19979103

Nc1nc(Cl)nc2c1ncn2C12C3O[C@H](CO)C(O)C1(COCc1ccccc1)[C@@H]32

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 8/20 0.51
ADORA2A P29274 3/20 0.47
PDE4D Q08499 2/20 0.44
PDE3A Q14432 2/20 0.44
PNP P00491 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
ADORA2B P29275 1/20 0.44
ADORA3 P0DMS8 1/20 0.42
ADORA1 P30542 1/20 0.42
ADRA1A P35348 1/20 0.42
NT5E P21589 8/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22700332 0.81 PDE2A (0.57) PDE2AADORA2APDE4DPDE3APNP
SCHEMBL19974427 0.78 ADORA2A (0.68) PDE2AADORA2APDE4DPDE3APNP
SCHEMBL19979098 0.73 LMNA (0.37) PDE2ALMNATP53NT5E
SCHEMBL19979260 0.72 PDE2A (0.49) PDE2AADORA2APDE4DPDE3APNP
SCHEMBL19974448 0.69 ADORA2A (0.55) PDE2AADORA2APDE4DPDE3APNP
SCHEMBL22700164 0.68 PDE2A (0.52) PDE2AADORA3NT5E
SCHEMBL19978932 0.67 PDE2A (0.49) PDE2AADORA2AADORA3NT5E
SCHEMBL21783562 0.67 PDE2A (0.62) PDE2AADORA2APDE4DPDE3AADORA2B
SCHEMBL9404549 0.67 ADORA2A (0.44) PDE2AADORA2APDE4DPDE3AADORA2B
SCHEMBL10709057 0.67 ADORA2A (0.48) PDE2AADORA2APDE4DPDE3APNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018049534-A1 NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT LCB PHARMA INC. (CA) 2018-03-22 WO disclosed